Bernd Schmidt
Chief Tech/Sci/R&D Officer at SENSORION
Bernd Schmidt active positions
Companies | Position | Start | End |
---|---|---|---|
SENSORION | Chief Tech/Sci/R&D Officer | 10/12/2023 | - |
Career history of Bernd Schmidt
Former positions of Bernd Schmidt
Companies | Position | Start | End |
---|---|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Bernd Schmidt
Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Statistics
International
Germany | 2 |
United Kingdom | 2 |
France | 2 |
Operational
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SENSORION | Health Technology |
Private companies | 1 |
---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Bernd Schmidt
- Experience